# Atropine Sulfate Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current, To Be Discontinued
- FDA package records: 21
- Latest FDA row update: 11/07/2025
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Accord Healthcare Inc. — Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) — FDA availability: Unavailable — updated: 08/17/2026
- Accord Healthcare Inc. — Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90) — FDA availability: Unavailable — updated: 08/17/2026
- Accord Healthcare Inc. — Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43) — FDA availability: Unavailable — updated: 08/17/2026
- Accord Healthcare Inc. — Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08) — FDA availability: Unavailable — updated: 08/17/2026
- Accord Healthcare Inc. — Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45) — FDA availability: Available — updated: 08/17/2026
- Accord Healthcare Inc. — Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08) — FDA availability: Unavailable — updated: 08/17/2026
- American Regent, Inc. — Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25) — FDA availability: Available — updated: 08/17/2026
- American Regent, Inc. — Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25) — FDA availability: Available — updated: 08/17/2026
- Amphastar Pharmaceuticals, Inc. — Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1) — FDA availability: Available — updated: 08/18/2026
- Fresenius Kabi USA, LLC — Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20) — FDA availability: Available — updated: 08/04/2026
- Hikma Pharmaceuticals USA, Inc. — Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10) — FDA availability: Available — updated: 08/13/2026
- Hospira, Inc., a Pfizer Company — Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)" — FDA availability: Unavailable — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)" — FDA availability: Not stated — updated: 11/07/2025
- Hospira, Inc., a Pfizer Company — Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2)  (NDC 0409-4911-34)" — FDA availability: Not stated — updated: 11/07/2025
- Hospira, Inc., a Pfizer Company — Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)" — FDA availability: Unavailable — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10) — FDA availability: Unavailable — updated: 08/07/2026
- Medefil, Inc. — Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91) — FDA availability: Available — updated: 08/17/2026
- Somerset Therapeutics, LLC — Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10) — FDA availability: Available — updated: 07/20/2026
- Somerset Therapeutics, LLC — Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25) — FDA availability: Available — updated: 07/20/2026
- Somerset Therapeutics, LLC — Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25) — FDA availability: Available — updated: 07/20/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/atropine-sulfate-injection)
- [JSON record](https://citefacts.com/shortages/atropine-sulfate-injection.json)